AOSSM 2022 Annual Meeting Recordings - no CME-Long-term Outcomes of an All-Arthroscopic Matrix-Assisted Autologous Chondrocyte Transplantation Technique

Long-term Outcomes of an All-Arthroscopic Matrix-Assisted Autologous Chondrocyte Transplantation Technique

Video Transcription

Video Summary

In this video, Antonio presents a study on the long-term outcomes of matrix-assisted autologous chondrocyte transplantation (ACI) for treating cardiac lesions in arthroscopic surgeries. The study included 36 patients with symptomatic grade III or IV cartilage lesions who underwent ACI. Follow-up was conducted for up to 10 years using MRI, patient-reported outcome measures, and arthroscopic evaluation. Results showed that T2 mapping values improved after surgery, MOCART scores remained stable, and patients had nearly normal cartilage based on ICRA microscopic score. Clinically, patients reported significant improvement in pain and activity levels. There was only one re-operation and no failures. Limitations included a small sample size and lack of a control group. The study concludes that ACI could be a long-lasting alternative for patients with focal chondral lesions in the knee.

Asset Caption

Antonio Madrazo-Ibarra, MD

Keywords

matrix-assisted autologous chondrocyte transplantation

cardiac lesions

arthroscopic surgeries

long-term outcomes

focal chondral lesions